Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1829, Issue 12, 2013, Pages 1266-1275

  Seuter, Sabine ^a   Pehkonen, Petri ^a   Heikkinen, Sami ^a   Carlberg, Carsten ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

ChIP seq; FAIRE seq; HDAC inhibitor; Open chromatin; VDR; Vitamin D

Indexed keywords

CALCITRIOL; FANCONI ANEMIA GROUP E PROTEIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HISTONE H3; NUCLEOTIDE; PROGRAMMED DEATH 1 LIGAND 2; VITAMIN D RECEPTOR;

ACUTE MONOCYTIC LEUKEMIA; ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENOME ANALYSIS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR DYNAMICS; NUCLEOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 84887574192     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.10.003     Document Type: Article

References (49)

1. Carlberg C., Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr. Top. Med. Chem. 2012, 12:528-547.
2. Perissi V., Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 2005, 6:542-554.
3. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J. 1998, 17:4905-4908.
4. Eberharter A., Becker P.B. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002, 3:224-229.
5. 3 receptor-corepressor partnership. FASEB J. 2000, 14:1455-1463.
6. 3 receptor signalling in prostate cancer cells. Oncogene 2004, 23:6712-6725.
7. Abedin S.A., Banwell C.M., Colston K.W., Carlberg C., Campbell M.J. Epigenetic corruption of VDR signalling in malignancy. Anticancer Res. 2006, 26:2557-2566.
8. 3. Nucleic Acids Res. 2008, 36:121-132.
9. 3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. J. Steroid Biochem. Mol. Biol. 2004, 89-90:245-249.
10. Gronemeyer H., Gustafsson J.A., Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 2004, 3:950-964.
11. Carlberg C., Seuter S. Dynamics of nuclear receptor target gene regulation. Chromosoma 2010, 119:479-484.
12. Tan J., Cang S., Ma Y., Petrillo R.L., Liu D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J. Hematol. Oncol. 2010, 3:5.
13. 3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Res. 2013, 41:110-124.
14. ENCODE-Project-Consortium, Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. Snyder, An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
15. 3 and its receptor. J. Steroid Biochem. Mol. Biol. 2007, 103:389-395.
16. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., Jurutka P.W. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 2008, 66:S98-S112.
17. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., Handunnetthi L., Handel A.E., Disanto G., Orton S.M., Watson C.T., Morahan J.M., Giovannoni G., Ponting C.P., Ebers G.C., Knight J.C. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010, 20:1352-1360.
18. 3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011, 39:9181-9193.
19. Meyer M.B., Goetsch P.D., Pike J.W. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 2012, 26:37-51.
20. Ding N., Yu R.T., Subramaniam N., Sherman M.H., Wilson C., Rao R., Leblanc M., Coulter S., He M., Scott C., Lau S.L., Atkins A.R., Barish G.D., Gunton J.E., Liddle C., Downes M., Evans R.M. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013, 153:601-613.
21. Carlberg C., Seuter S., Heikkinen S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res. 2012, 32:271-282.
22. Carlberg C., Campbell M.J. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013, 78:127-136.
23. 3 on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 2010, 1803:1276-1286.
24. 3-dependent repression of interleukin-12B. Biochim. Biophys. Acta 2011, 1813:810-818.
25. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 1980, 26:171-176.
26. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:R34.
27. Giresi P.G., Lieb J.D. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods 2009, 48:233-239.
28. Rashid N.U., Giresi P., Ibrahim J.G., Sun W., Lieb J.D. ZINBA integrates local covariates with DNA-seq data to identify broad and narrow regions of enrichment, even within amplified genomic regions. Genome Biol. 2011, 12:R67.
29. Robinson J.T., Thorvaldsdottir H., Winckler W., Guttman M., Lander E.S., Getz G., Mesirov J.P. Integrative genomics viewer. Nat. Biotechnol. 2011, 29:24-26.
30. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
31. Giresi P.G., Kim J., McDaniell R.M., Iyer V.R., Lieb J.D. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res. 2007, 17:877-885.
32. Song L., Zhang Z., Grasfeder L.L., Boyle A.P., Giresi P.G., Lee B.K., Sheffield N.C., Graf S., Huss M., Keefe D., Liu Z., London D., McDaniell R.M., Shibata Y., Showers K.A., Simon J.M., Vales T., Wang T., Winter D., Zhang Z., Clarke N.D., Birney E., Iyer V.R., Crawford G.E., Lieb J.D., Furey T.S. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011, 21:1757-1767.
33. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L.J., Grippo J.F., Hunziker W. Two nuclear signalling pathways for vitamin D. Nature 1993, 361:657-660.
34. Mohn F., Schubeler D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet. 2009, 25:129-136.
35. Talbert P.B., Henikoff S. Spreading of silent chromatin: inaction at a distance. Nat. Rev. Genet. 2006, 7:793-803.
36. Burd C.J., Ward J.M., Crusselle-Davis V.J., Kissling G.E., Phadke D., Shah R.R., Archer T.K. Analysis of chromatin dynamics during glucocorticoid receptor activation. Mol. Cell. Biol. 2012, 32:1805-1817.
37. Dang C.V. MYC on the path to cancer. Cell 2012, 149:22-35.
38. Bristow R.G., Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 2008, 8:180-192.
39. Mendoza-Parra M.A., Walia M., Sankar M., Gronemeyer H. Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics. Mol. Syst. Biol. 2011, 7:538.
40. Jakobsen J.S., Waage J., Rapin N., Bisgaard H.C., Larsen F.S., Porse B.T. Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries. Genome Res. 2013, 23:592-603.
41. Narlikar G.J., Fan H.Y., Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002, 108:475-487.
42. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
43. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
44. Downs J.A., Nussenzweig M.C., Nussenzweig A. Chromatin dynamics and the preservation of genetic information. Nature 2007, 447:951-958.
45. 3. J. Biol. Chem. 2009, 284:8073-8082.
46. Montecino M., Frenkel B., van Wijnen A.J., Lian J.B., Stein G.S., Stein J.L. Chromatin hyperacetylation abrogates vitamin D-mediated transcriptional upregulation of the tissue-specific osteocalcin gene in vivo. Biochemistry 1999, 26:1338-1345.
47. Rada-Iglesias A., Wallerman O., Koch C., Ameur A., Enroth S., Clelland G., Wester K., Wilcox S., Dovey O.M., Ellis P.D., Wraight V.L., James K., Andrews R., Langford C., Dhami P., Carter N., Vetrie D., Ponten F., Komorowski J., Dunham I., Wadelius C. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. Hum. Mol. Genet. 2005, 14:3435-3447.
48. Halsall J., Gupta V., O'Neill L.P., Turner B.M., Nightingale K.P. Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. PLoS One 2012, 7:e33453.
49. Boudadi E., Stower H., Halsall J.A., Rutledge C.E., Leeb M., Wutz A., O'Neill L.P., Nightingale K.P., Turner B.M. The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenetics Chromatin 2013, 6:11.